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The in vivo regulation of $.atlenosylmethionine synth=tas¢, it key enzyme in mcthionin¢ metaboli=m, itl~ far unknown, The ¢n~m¢ activity has 
been shown to tm modulated by $lutathion¢ and tl~e oxidation =titte of it~ tulfl'tydryl groups, Analy,=iti of the protein re.qu¢nc¢ has revealed the 
prer~mce of putative phottphorylation sites. A mixed regulatory mechanism combining pho~phorylation a d the oxido/reduetion ofsull'hydwI lroups 
is proposed. The role of =lutathione in this mcchani=im isalso discussed, 
S.Adenosylmethionirm; Glutathione; Sulfl~ydryl group: Phosphorylation 
I. INTRODUCTION 
S-Adenosylmethionin¢ (AdoMet) synthetase ts the 
enzyme responsible for the synthesis of AdoMet using 
methioninz and ATP  as substrates [l]. Its importance is 
due to the fact that AdoMet is the main methyl donor 
group for most of the transn~ethylation reactions in the 
cell, As mentioned by Cantons [2]. no other biological 
compound, including ATP, participates in as many re- 
actions as AdoMet. Moreover, AdoMet  synthesis is the 
main pathway for mcthionin¢ metabolism in the liver 
[3], where 6--8 g of AdoMet are produced daily in an 
adult individual. It is also known that the AdoMet syn. 
thetase activity is reduced in hepatic pathologies [4]. 
Therefore, the study of AdoMet synthesis is subject of 
great importance, sp~cially in the liver. 
For a ions time it has been known that there are 
several AdoMet synthetase forms, which were called ct 
(Mr 210 kDa), fl (Mr i l0 kDa) and T 090 kDa) [S]. 
However, it was not clearly established if these forms 
were different proteins or different oligomeric forms of 
the same subunit. Recently, it has been shown that only 
the ,t and ,8 forms are present in the t~ormal adult rat 
liver [6]. Both forms on SDS-PAOE show a single band 
with an estimated M,  of around 48 kDa. Tryptic l~ptide 
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mapping of both forms present he same profile on 
HPLC and antibodies raised against he 110 kDa form 
(low-Me form) are able to recognize both AdoMct syn- 
thetas¢ [7]. Moreover, the incubation of the 210 kDa 
form (high-Mr form) in the presence of 1.8 M LiBr 
converts this form into the low-Mr form of the enzyme 
[8]. All these data led Cabrero et al. [8] to suggest that 
the high-M, form is a tetramer and the low-Mr form a 
dimer of the same subunit. 
2. ROLE OF SULFHYDRYL GROUPS ON AdoMct 
SYNTHETASE 
2.1. In vitro effect of N.ethylmaleimide modification on 
AdoMet synthetase 
AdoMct synthetase can be modified with N-eth- 
ylmaleimide (NEM), showing an incorporation of2 me! 
NEM/mol of subunit in both, the high- and the low-Mr 
forms. This modification causes a loss ot" the enzyme 
activity in both enzyme forms. Also, when two of the 
ten sulfhydryl groups present in the protein are modi- 
fied per subunit, its analysis by gel filtration chromatog- 
raphy shows a change in M, for the 210 kDa form. This 
form now appears with an estimated M, of 110 kDa, 
while the NEM-modified low-M, form does not change 
its elution position [9]. 
When the pattern of the NEM-modification reaction 
and the reduction of the enzyme activity are compared 
for both enzyme forms, it can be observed that a loss 
of about 80% of the activity is accomplished while only 
one NEM group is incorporated per AdoMet synthe- 
tase subanit. This result has been interpreted as indica- 
tive that one of the sulfhydryl groups modified by this 
procedure isprimarily responsible for the reduction in 
the enzyme activity. This group has been identified as 
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the sulfhydryl group of Cys- 150 of the protein sequence 
[10]. This finding differs from what was expected from 
the data published on the Escherichi. colt enzyme, 
where Cys-90 of the sequence wax modified [11], This 
residue corresponds to Cys-105 in the rat liver AdoMet 
synthetase. Cys-150 of the rat liver enzyme also corre- 
sponds to another E. colt Cys. number 135 of tile se- 
quence [I0]. These cysteine residues, rat liver Cys-150 
and E. coil Cys-135. are located close to the consensus 
sequen~ for the ATP-binding site. In fact, NEM r~ac- 
lion can be partially protected, by increasing the time 
needed to obtain 50% of the modification, by including 
the enzyme substrates (methionine) or analogues of the 
substrates (AMP-PNP) in the incubation mixture 
[10.11]. 
2.2. Glutathioa¢ ,rid AdaltCet sy, thurase relationship 
Related to these findings, in rive experiments carried 
out by the injection of buthionine sulfoximine (B$O. a 
co~pound that inhibits glutathione synthesis) [12] have 
ahown that a 30% reduction in the 81utathione (GSH) 
concentration goes parallel with a 60% inhibition in the 
AdoMet synthmase activity in rat liver it 3]. The altera- 
tion of these parameters is accompanied bythe appear- 
ance of variations in the hepatocytc mitochondrial 
shape and also affects the rough endoplasmic rtticulum, 
These changes can be overcome by tile injection of a 
monoethylester of glutathione, a permeable derivative 
of glutathione [13]. Similarly. rats treated with CCI~ 
present a decreased AdoMet synthetase activity and 
reduced GSH levels, effects that can be prevented by 
intramuscular injection of AdoMet [14], 
All the above zesults indicate the importance of 
sulfhydryl groups in AdoMet synthttase activity. The 
role of these groups may b~ rclat~ to the maintenance 
of the enzyme oligomeric state. It should also be consid- 
ered that different groups may be involved in the events 
produced in each enzyme form. In addition, these data 
suggest a possible role for glutathion¢ in the protection 
of these groups against oxidation. 
Therefore. the effect of glutathione on AdoMet syn- 
thetase activity and b~haviour has been studied, show- 
ing that the presence of GSSG (glutathione oxidized 
form) can inhibit the enzyme activity in vitro and. that 
this effect can be modulated by GSH (glutathione re- 
duced form) [15], Therefore, a regulation by the ratio 
GSH/GSSG is expected. Changes in the kinetic behavi- 
our of the high-Mr tbrm of the enzyme when it is sub- 
jected to chromatography on thiopropyl Sepharose 6B 
(using sulf'nydryl groups as the attachment site) and 
clutcd with GSH have also been observed [15]. These 
changes can be summarized as a disappearance of a 
high KmM,i component ofits kinetics and the appearance 
of a non-sigmoidal (hyperbolic) kinetic shape. This al- 
teration can be due to the occurrence of some sulfhydryl 
groups of the protein in the reduced state. The: Ibrmer 
presence of two kinetic omponents could be due to the 
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Fig. I, AdoMct synthctase tructural features. The hydrophobicit~, of
the dcdu~d sequence of AdoM¢~ syn|lttta~: spas anulyxed by the 
K>.t=-Doolittl¢ al¢orlthm. The relative Io¢;1|iOll of putative phospho- 
rylation sites are shown. 
coexistence of an oxidized and a reduced form of this 
210 kDa enzyme. No change in the kinetic behaviour 
for mtthionin¢ was observed with the low-M, form, 
maybe due to a different configuration of the enzyme 
or to the fact that different sulfl~ydryl groups are in- 
volved in the binding, leading to a rccluced imer that 
has different characteristics than the reduced tetranaer 
[15.16]. 
The kinetic changes observed for the high-Mr form 
correlate with a variation in its behaviour on $DS- 
PAGE, where a reduction in the subunit M, for this 
enzyme is observed [16]. These results and the former 
about its kinetic behaviour make us to suggest that the 
low-M, form is probably an oxidized-dimer configura- 
tion that may change to a reduced imer under sp~iai 
conditions (e,g. thiopropyl $epharose 68 chromatogra- 
phy). but that may or may not be able to b~ome a 
tetramer and. therefore, does not show the same behav- 
tour as the high-M, form. Its capacity to form a tetramer 
could be modulated by a modification such as phospho- 
rylation, that can interfere with the association of two 
directs. 
3. PROPOSAL 
At the moment here is no description of any phos- 
phorylation reaction involving AdoMct synthetase, 
cvcn when it could be expected. The a,aljsis of the 
deduced ~¢quence shows several putative phosphoryla- 
tion sites, 6 for protein kinase C, I for protein kinase 
cAMP-dependent. 2 for Ca~'-calmodulin-dependent 
protein kinase and S for casein lfinas¢ It (Fig, I). Based 
on :hose data and the hydrophobicity profile it could be 
expected that at least one PK-C and one CK-II site are 
2 
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Fig, 2, Scheme of thc proposed mixed ~guhttory m=¢lmnism of AdoMet syathetau:, Panel A represents tha eh=nlles in th= tctmm©r form ~md pttn¢l 
B shows the r~¢tions involving the dim~r form. Dash~ arrows showy reactions ~trriua out under tip..,cMI conditions, in the prcscne~ of LiBr or 
N.cthylmal¢imid¢ (rca¢tionti 3 and 1 |), ;tad by bindinB to a thioprapy! Scpharos¢ 6B column (reatetion 4). Filled arrows indi~t¢ r~ctiontL lhown 
in vitro or proposed and that could occur in vivo under ~imilar conditionti, AdoM=t slyatlmta~ subunits thttt differ in the oxidiz=d/rcduce.d tmlfhydryl 
groups have b¢¢n drawn at~ distin¢t polygonal forms, as di~usse.d in the text. 
phosphorylated in vivo. This deduction isbased on the 
present, of some of these putative phosphorylation sites 
on the most hydrophilic area of' the protein (Fig. 1). 
There are other results that also suggest a possible reg- 
ulation by a phosphorylation mechanism. These are 
based on the increase of the activity of several trans- 
methylation reactions due to phosphorylation of the 
enzymes involved, as is the case for glycine methyltrans- 
ferase [17] and phospholipid methyltransferase in the 
liver [18,19]. All these methyltransferases use AdoMet 
as the methyl donor group for their reactions, therefore, 
an increase in their activities will need AdoMet higher 
production, which can only be done by an increase in 
AdoMct synthctase activity, suggesting that there 
should be a coordination between the rvgulation of 
these enzymes and AdoMet synthctas¢. At the same 
time the increase in AdoMet synthetase activity should 
not be very dramatic because changes in the ratio 
AdoMet/AdoHcy regulate mtthyltransferase activities 
[20]. 
Other possible regulatory mechanisms, involving a 
modulation of the AdoMet synthetas¢ mRNA levels 
have been also analy~d under conditions where the 
enzyme activity is reduced (CC14 treatment), The results 
obtained s~m to exclude this tYl~ of regulation, since 
there are no changes observed in these levels [14]. 
Based on all tll= results described we propose a regu- 
latory mechanism combining oxidation/reduction states 
of' the enzyme and phosphorylation (Fig. 2). The tetra- 
mer could appear in either a reduced or an oxidized 
state (reactions I,I0) as suggested by the results ob- 
tained after chromatography on a thiopropyl .~pharose 
6B column [I 5,16]. As mentioned above, AdoMet syn- 
thetas¢ presents consensus sequences for phosphoryla- 
tion by several protein kinases (Fig. 1). Therefore, it 
could be expected that both th, redu~d tetramcr and 
the oxidi~d tetramer are phosphorylated by any of 
these protein kinas¢s (reactions 6, 7). These phos- 
phorylated forms could be dephosphor~'iated by 
phosphatases reverting these reactions. In addition, th= 
purified tetram,," incubated in the pr~sen~ of GSSG 
leads to the apl~aran~ of an inactive oxidized mono- 
mer [I $] (r¢action 2). 
Similarly, the dimer could appear in a reduced or an 
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oxidi~d form (reaction 4). Since the K~,M, , value for the 
dimer ~nd the oxidized tetramer are identical [15], it is 
suggested that the dimer appears as an oxidized form. 
A reduced dimer has been obtained only after chroma- 
tography on a thiopropyl Sepharose 6B column [15]. In 
contrast to the results obtained with the reduced tetra- 
mer, the reduced dimer does not show any kinetic 
change or molecular weight variation after this chroma- 
tography. Therefore, we suggest hat the sulfhydryl 
group(s) reduced in the dimer are different han the 
one(s) involved in binding of the tetramer, and are 
drawn in a different form. 
The incubation of the dimer in the presence of GSSG 
leads to the formation of an inactive monomer [1S], that 
should be an oxidized form (reactions 5, 12). Like for 
the tetramer, the dimer could be phosphorylated in ei- 
ther of its forms, reduced or oxidized (reaction 8). A 
possible phosphorylation of the reduced dimer cannot 
be excluded, but this form only seems to be formed by 
thiopropyl Sepharose 6B chromatography, and there- 
fore of no physiological significance. The monomer 
originated by oxidation could also be formed I)y phos- 
phorylation (reaction 9). The phosphorylation reactions 
involving direct and monomer could also be reverted by 
the action of phosphatases (reactions 8, 9). 
Finally, since our hypothesis is that the dimer is an 
oxidized form we suggest that the conversion of the 
tctramer to the dimer is produced from the oxidized 
tetramer by reaction 3. or from the oxidized- 
phosphorylated tetramcr by reaction I l, A possible ag- 
gregation reaction of the dimer to form a tetramer ap- 
pears to be excluded based on the data available [8,9]. 
This mixed mechanism combining phosphorylation 
and oxide/reduction fits with the structural fcatur"s of 
AdoMet synthetase and could explain the complexity of 
its regulation. Moreover, this proposal indicates that to 
fully establish this regulatory mechanism, phosphoryla- 
tion experiments need to be carried out. 
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